Janelle-Cheri Angella Millen, MBBS

Janelle-Cheri Millen practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Janelle-Cheri Millen's NPI, 1285086157, was assigned on July 5, 2016. Janelle-Cheri Millen graduated from University of the West Indies Faculty of Medical Sciences in 2015. Janelle-Cheri Millen holds California license A178504.

Janelle-Cheri Millen's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Janelle-Cheri Millen also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Janelle-Cheri Millen's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. Janelle-Cheri Millen is also affiliated with Bellevue Medical Center. The medical group on file is UNMC Physicians. Dmand AI also links Janelle-Cheri Millen to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Janelle-Cheri Millen practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Janelle-Cheri Millen's primary specialty in the NPI Registry, under taxonomy code 208600000X. Janelle-Cheri Millen is board certified in complex general surgical oncology by the American Board of Surgery. Dmand AI has Janelle-Cheri Millen's licenses on file in 2 states: California and Nebraska.

Dmand AI lists cancerous skin growth removal among the conditions Janelle-Cheri Millen treats.

CMS counts 26 Medicare patients who saw Janelle-Cheri Millen in 2024. 73% of them have cancer, and 65% have high blood pressure. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Janelle-Cheri Millen's median patient age at 70, with 99% women.

In 2023, Janelle-Cheri Millen wrote 15 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $71 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Janelle-Cheri Millen for performance year 2024, reported as part of a group. Janelle-Cheri Millen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 32 procedures of mastectomy by Janelle-Cheri Millen, more than 88% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Janelle-Cheri Millen, published from 2020 to 2024. 2024 was the busiest year, with 5. The most frequent topics are Breast Neoplasms, Mammaplasty and Mastectomy. Janelle-Cheri Millen has published most often in Ann Surg Oncol. Janelle-Cheri Millen's most frequent co-authors are Crystal Elizabeth Fancher, MD, Udai Sibia, MD and Darwin Noel Ang, MD.

CMS Open Payments shows 14 general payments to Janelle-Cheri Millen from 7 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Smith & Nephew, Inc. paid the most, $286.

Janelle-Cheri Millen graduated from University of the West Indies Faculty of Medical Sciences in 2015.

Janelle-Cheri Millen is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.